OSAKA -- Four Japanese institutions will collaborate on transplanting tissue grown from induced pluripotent stem cells taken from donors into patients suffering from age-related macular degeneration, a hard-to-cure eye disease.
The initiative, announced Monday, will break new ground in that the cost of transplanting iPS-derived tissue will be significantly reduced by using stocked cells provided by donors, instead of using the patients' own cells as in a previous case involving a sufferer of the same disease.
